Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Immune System Diseases × Lymphocyte Depletion × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1

Conditions

Myelodysplastic Syndromes 1 Leukemia 1 Immune System Diseases 1 Graft vs Host Disease 1

Interventions

ponatinib 1 ibrutinib 1 ibritumomab tiuxetan 1 cirmtuzumab 1 Vorinostat 1 Rituximab 1 Melphalan 1 Lymphocyte Depletion 1 Imatinib Mesylate 1 Etoposide 1 Cytarabine 1 Carmustine 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00000591 2016-04-15

T-Cell Depletion in Unrelated Donor Marrow Transplantation

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed

MyeloidOther hematologic neoplasm

Graft vs Host Disease, Immune System Diseases, Leukemia, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡